IBL Healthcare Limited - IBLHL
Rs 34.48
Change 0.38
On May 17
Trades end of day
| Last trade on | May 17, 2024 | Day's range | Rs 34.10 - 35.00 |
|---|---|---|---|
| Change | Rs 0.38 | 52 week range | Rs 29.00 - 43.50 |
| Open | Rs 34.10 | Volume | 173,000 |
| Close | Rs 34.48 | Previous Close | Rs 34.48 |
IBLHL Trade Activity
| Period | High | Low | Volume |
|---|---|---|---|
| 1M | 35.57 | 31.00 | 3,629,000.00; Avg 181,450.00 |
| 3M | 35.57 | 30.02 | 6,437,500.00; Avg 107,291.00 |
| 6M | 42.72 | 29.37 | 21,901,000.00; Avg 179,516.00 |
| 1Y | 42.72 | 29.37 | 34,750,000.00; Avg 141,260.00 |
Latest Annual Financials
| Financial Year | 2023 | O/S Shares | 71.40m |
|---|---|---|---|
| Net Profit | Rs 308.96m | Market Cap | Rs 2,461.72m |
| EPS | 4.33 | P/E | 7.97 |
| Par | Rs 10.00 | Net Worth | Rs 591.59m |
| Dividend | Rs 0.00 | Dividend Yield | 0.00 |
| Right | 0.00 | Long Term Debt | 3.13 |
| Fixed Assets | 591.59m | Net Sales | 4,027.87m |
| Share High | 42.72 | Retained Earnings | 1,393.17m |
| Premium | Rs 0.00 | Bonus | 2.00% |
| Paid up Capital | 713.96m | Working Capital | 1,518.66m |
| Share Low | Rs 29.45 | Price at BOD Meeting | Rs 33.83 |
| Share Average | Rs 36.09 | Depreciation | 1.48m |
| Export Sales | 0.00m | Financial Expense | 65.74m |
The company is in the Pharmaceuticals sector.
Other Companies in This Sector
| Company | Current | Change | Date |
|---|---|---|---|
| Abbot Laboratories | Rs 669.26 | 1.20% | May 17, 2024 |
| AGP Limited | Rs 91.31 | -0.75% | May 17, 2024 |
| Citi Pharma Limited | Rs 31.89 | -0.03% | May 17, 2024 |
| Ferozsons Laboratories Limited | Rs 252.67 | -0.52% | May 17, 2024 |
| Glaxosmithkline | Rs 137.26 | 0.74% | May 17, 2024 |
| Glaxo Healthcare Pakistan | Rs 120.23 | -3.20% | Jan 30, 2023 |
| Haleon Pakistan Limited | Rs 264.86 | 5.10% | May 17, 2024 |
| Highnoon Laboratories | Rs 678.99 | 0.09% | May 17, 2024 |
| Hoechst Pakistan Limited | Rs 1,526.97 | 3.52% | May 17, 2024 |
| IBL Healthcare Limited | Rs 34.48 | 1.11% | May 17, 2024 |
| IBL Healthcare Limited (r) | Rs 0.00 | 0.00% | May 18, 2024 |
| Macter International Limited | Rs 89.85 | -0.04% | May 16, 2024 |
| Macter International Limited (r) | Rs 0.00 | 0.00% | May 18, 2024 |
| Otsuka Pakistan Limited | Rs 129.39 | 1.24% | May 17, 2024 |
| Sanofi-aventis Pharmaceutical Pakistan Limited | Rs 870.00 | 0.00% | Oct 27, 2023 |
Shareholding Pattern
| Year | Individual | Institutions | Investment Companies | Foreign Investors | Government | Shareholders | Other |
|---|---|---|---|---|---|---|---|
| 2023 | 15.10% | 0.02% | 72.47% | 1.02% | 0.00% | 5,041.00 | 10.61% |
| 2022 | 13.44% | 0.02% | 72.47% | 1.01% | 0.00% | 4,883.00 | 12.28% |
| 2021 | 13.08% | 0.02% | 72.47% | 0.94% | 0.00% | 4,554.00 | 12.68% |
| 2020 | 7.12% | 0.02% | 74.84% | 0.86% | 0.00% | 5,233.00 | 16.35% |
| 2019 | 19.53% | 1.92% | 74.63% | 0.88% | 0.00% | 5,362.00 | 3.04% |
| 2018 | 19.21% | 1.99% | 74.63% | 0.87% | 0.00% | 5,430.00 | 3.30% |
| 2017 | 17.94% | 1.09% | 77.65% | 0.88% | 0.00% | 5,403.00 | 2.41% |
| 2016 | 18.08% | 2.30% | 78.16% | 0.90% | 0.00% | 5,231.00 | 0.47% |
| 2015 | 15.82% | 2.60% | 78.87% | 0.95% | 0.00% | 4,795.00 | 1.64% |
| 2014 | 18.32% | 2.03% | 77.83% | 0.83% | 0.79% | 4,076.00 | 0.20% |
| 2013 | 18.94% | 1.12% | 78.62% | 0.83% | 0.00% | 4,076.00 | 0.49% |
| 2012 | 19.78% | 1.48% | 77.50% | 0.87% | 0.00% | 4,043.00 | 0.37% |
| 2011 | 20.13% | 2.46% | 77.10% | 0.04% | 0.00% | 4,021.00 | 0.27% |
| 2010 | 20.19% | 2.77% | 76.73% | 0.04% | 0.00% | 4,032.00 | 0.27% |
| 2009 | 15.77% | 3.19% | 78.35% | 0.04% | 0.00% | 4,079.00 | 2.65% |